Innoviva (INVA) Long-Term Debt Repayments (2010 - 2012)
Innoviva (INVA) reported Long-Term Debt Repayments of $13000.0 for Q2 2012, down 74.51% on a YoY basis from $51000.0 in Q3 2011, and down 76.79% quarter-over-quarter from $56000.0 in Q1 2012.
Innoviva (INVA) Long-Term Debt Repayments (2010 - 2012) Analysis & Trends
Innoviva has reported Long-Term Debt Repayments for 3 years, with the latest figure at $13000.0 in Q2 2012.
- For the quarter ending Q2 2012, Long-Term Debt Repayments fell 74.51% year-over-year to $13000.0; the trailing twelve-month figure through Dec 2012 stood at $69000.0 (down 66.5% YoY), and the FY2012 full-year result was $69000.0, down 66.5% from the prior year.
- Long-Term Debt Repayments for Q2 2012 stood at $13000.0, down from $56000.0 in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $62000.0 in Q1 2011, with the low at $13000.0 in Q2 2012.
- Historically, Long-Term Debt Repayments has averaged $46250.0 across 3 years, with a median of $52000.0 in 2011.
- Annual changes were most pronounced in 2011 — Long-Term Debt Repayments grew 11.11% — and 2012, when it sank 74.51%.
- Innoviva's Long-Term Debt Repayments stood at $36000.0 in 2010, then rose by 11.11% to $40000.0 in 2011, then slumped by 67.5% to $13000.0 in 2012.
- The last three Long-Term Debt Repayments figures came in at $13000.0 (Q2 2012), $56000.0 (Q1 2012), and $40000.0 (Q4 2011), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 13,000.00 |
| Jun 30, 2012 | 13,000.00 |
| Mar 31, 2012 | 56,000.00 |
| Mar 31, 2012 | 56,000.00 |
| Dec 31, 2011 | 40,000.00 |
| Dec 31, 2011 | 40,000.00 |
| Sep 30, 2011 | 53,000.00 |
| Sep 30, 2011 | 53,000.00 |
| Jun 30, 2011 | 51,000.00 |
| Jun 30, 2011 | 51,000.00 |
| Mar 31, 2011 | 62,000.00 |
| Mar 31, 2011 | 62,000.00 |
| Dec 31, 2010 | 36,000.00 |
| Dec 31, 2010 | 36,000.00 |
| Sep 30, 2010 | 59,000.00 |
| Sep 30, 2010 | 59,000.00 |